DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kytril (Granisetron Hydrochloride) - Current Clinical Trials

 
 



Kytril Related Clinical Trials

PK, Tolerability and Safety of the co-Administration of Sancuso´┐Ż (Transdermal Granisetron) and IV Granisetron [Completed]

Safety Study of Electrocardiogram (ECG) Effects of Sancuso« (Granisetron TDS) [Completed]

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron [Completed]

Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles [Active, not recruiting]

Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients [Withdrawn]

A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy [Completed]

Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects [Completed]

Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting [Not yet recruiting]

Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients [Completed]

Granisetron Versus Ondansetron: Comparative Effects on ECG, QTc [Completed]

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy) [Recruiting]

Granisetron 1 mg Tablets, Non-fasting [Completed]

Granisetron 1 mg Tablets Under Fasting Conditions [Completed]

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant [Completed]

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy [Recruiting]

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years [Not yet recruiting]

Drugs to Reduce the Side Effects of Chemotherapy [Completed]

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years [Not yet recruiting]

An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects [Recruiting]

Oral Versus Transdermal Ondansetron for Women With Cervical Cancer Receiving Chemoradiation [Recruiting]

Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study [Terminated]

Sancuso´┐Ż for Gastroparesis: An Open Label Study. [Recruiting]

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years [Recruiting]

APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer [Completed]

AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors [Completed]

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC) [Completed]

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy [Completed]

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease [Active, not recruiting]

The Antigagging Effect of Granisetron (Kytril), an Antiemetic Drug, in Dental Situations [Not yet recruiting]

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects [Completed]

A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions [Completed]

A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions [Completed]

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting [Completed]

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma [Active, not recruiting]

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial [Completed]

To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV) [Completed]

A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin [Completed]

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer [Completed]

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC [Completed]

Triciribine and Carboplatin in Ovarian Cancer [Active, not recruiting]

Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting [Completed]

An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients [Completed]

Rituximab and Combination Chemotherapy Followed By Thalidomide in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Active, not recruiting]

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy [Recruiting]

A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy [Completed]

A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy [Completed]

Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy [Completed]

Palonestron, Granisetron and Ramosetron for Prevention of Postoperative Nasea and Voming After Laparoscopic Abdominal Surgery [Recruiting]

A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea [Completed]

Interaction Between tropis├ętron / granis├ętron - parac├ętamol [Completed]

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy [Active, not recruiting]

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) [Completed]

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP [Not yet recruiting]

A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) [Completed]

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer [Completed]

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy [Completed]

Tick-borne Encephalitis and Positive Borrelial Antibodies [Recruiting]

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas [Terminated]

Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter [Terminated]

Observational Study of Perioperative Chemotherapy in Gastric Cancer [Active, not recruiting]

Incidence of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With the Docetaxel-Cyclophosphamide Regimen in Early Breast Cancer Patients [Completed]

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) [Completed]

Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy [Completed]

Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer [Active, not recruiting]

S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia [Withdrawn]

Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet [Recruiting]

Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy [Recruiting]

Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients [Recruiting]

Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix [Completed]

Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma [Completed]

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017